All women, regardless of their racial or ethnic origin or heritage, are at risk of developing breast cancer. Variations in breast carcinoma incidence rates among multicultural populations suggest that etiologic factors differ in their biologic expression and impact on disease outcome. Key among thos
Role of community risk factors and resources on breast carcinoma stage at diagnosis
✍ Scribed by Pamela L. Davidson; Roshan Bastani; Terry T. Nakazono; Daisy C. Carreon
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 110 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
BACKGROUND
The current study investigated the individual and community determinants of breast carcinoma stage at diagnosis (BCSAD) using multiple data sources merged with cancer registry data. The literature review yielded 5 studies that analyzed cancer registry data merged with community‐level variables (1995–2004).
METHODS
Community variables constructed for the current study reflected social and economic risk factors, physician supply, and health maintenance organization penetration. Multivariate logistic regression was used to identify the significant predictors of increasingly progressive BCSAD.
RESULTS
Disparities remained for black and Hispanic females in California, who were least likely to be diagnosed early compared with their white counterparts. Younger (< 40 years) and middle‐aged (40–64 years) females were less likely to be diagnosed with early BCSAD, compared with older females (≥ 65 years). Utilizing services at hospitals serving a lower volume of patients with breast carcinoma was associated with later BCSAD. After controlling for individual‐level factors, community‐level variables constructed at the census block group and county level were tested. If a woman resided in a neighborhood with greater percentages of female‐headed households, persons living below the poverty level, less educated people, and more recent immigrants, then her chances of being diagnosed at an earlier stage were diminished. If, conversely, she resided in a neighborhood with greater percentages of females ≥ 65 years (a proxy for Medicare coverage), her access to medical care and the probability of earlier BCSAD increased. County‐level insurance rates and residing in counties where greater percentages of women ever had a mammogram were associated with in situ and early‐stage diagnosis. Similarly, the supply of primary care physicians and radiologists was associated positively with earlier BCSAD.
CONCLUSIONS
Results confirmed community‐level predictors of socioeconomic and delivery system context matter, although the individual‐level predictors showed a stronger effect. Nevertheless, analysis of community variables is promising for guiding and evaluating the effects of health policy and developing community and delivery system interventions for earlier detection and treatment of breast carcinoma. Cancer 2005. © 2005 American Cancer Society.
📜 SIMILAR VOLUMES
## Abstract Incidence rates for breast carcinoma __in situ__ (CIS) have increased markedly over the past 20 years. Breast CIS, detected primarily on mammography, now represents 30–45% of all screened detected breast cancers. We conducted a large population‐based case‐control study to evaluate the i
## Background: The incidence of breast carcinoma in singapore has nearly doubled over the past 25 years. this prospective case-control study involving 1086 women (204 cases and 882 controls) was conducted to determine significant factors associated with the risk of breast carcinoma among chinese wo
## Abstract We examined the effects of cumulative risk, resource, and protective factors on the language and math achievement scores and school problem behaviors of a sample of 549 10–14‐year‐old, economically disadvantaged Latino youths. Findings indicated that as the number of risk factors increa
## Abstract ## BACKGROUND The purpose of the current study was to investigate the association between insulin resistance (which was measured using fasting blood C‐peptide) and its joint association with insulin‐like growth factors (IGF‐1, IGF‐2, and IGF binding protein‐3 [IGFBP‐3]) on the risk of